HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michel Hamon Selected Research

Michel Hamon Research Topics

Disease

21Neuralgia (Stump Neuralgia)
01/2018 - 12/2002
20Pain (Aches)
01/2019 - 04/2002
17Hyperalgesia
01/2018 - 12/2002
10Mood Disorders (Mood Disorder)
05/2013 - 05/2002
9Pulmonary Hypertension
09/2012 - 04/2002
6Inflammation (Inflammations)
01/2019 - 06/2003
6Hyperplasia
11/2006 - 03/2002
5Hypersensitivity (Allergy)
10/2014 - 11/2008
5Depressive Disorder (Melancholia)
05/2014 - 01/2007
5Hypoxia (Hypoxemia)
09/2012 - 04/2002
5Schizophrenia (Dementia Praecox)
05/2008 - 03/2004
4Chronic Pain
10/2014 - 06/2003
4Bradycardia
04/2011 - 09/2002
4Familial Primary Pulmonary Hypertension
11/2006 - 03/2002
3Cognitive Dysfunction
04/2012 - 03/2002
3Parkinson Disease (Parkinson's Disease)
08/2011 - 08/2009
3Alcoholism (Alcohol Abuse)
12/2008 - 01/2002
3Hypothermia
05/2006 - 05/2003
2Alzheimer Disease (Alzheimer's Disease)
01/2020 - 01/2020
2Major Depressive Disorder (Major Depressive Disorders)
01/2020 - 01/2009
2Hypertrophy
09/2012 - 08/2003
2Memory Disorders (Memory Loss)
08/2011 - 02/2010
2Parkinsonian Disorders (Parkinsonism)
04/2011 - 08/2009
2Peripheral Nerve Injuries
02/2010 - 04/2007
2Diabetic Neuropathies (Diabetic Neuropathy)
02/2007 - 07/2004
2Sleep Deprivation
08/2006 - 01/2006
2Vascular Remodeling
05/2005 - 04/2002
2Alcohol Withdrawal Seizures
05/2004 - 01/2003
2Alcohol Withdrawal Delirium (Delirium Tremens)
05/2004 - 01/2003
2Fibrosis (Cirrhosis)
02/2004 - 12/2002
1Neurobehavioral Manifestations
01/2020
1Central Nervous System Diseases (CNS Diseases)
12/2019

Drug/Important Bio-Agent (IBA)

24Serotonin (5 Hydroxytryptamine)IBA
02/2017 - 01/2002
14Antidepressive Agents (Antidepressants)IBA
01/2020 - 07/2004
8Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
05/2006 - 03/2002
75-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
11/2008 - 05/2002
6Opioid Analgesics (Opioids)IBA
11/2015 - 03/2004
5Serotonin ReceptorsIBA
01/2020 - 01/2002
5Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2015 - 02/2008
5Analgesics (Analgesic Drugs)IBA
01/2014 - 12/2002
5Fluoxetine (Prozac)FDA LinkGeneric
04/2012 - 08/2003
4Proteins (Proteins, Gene)FDA Link
12/2019 - 10/2003
4NeuropeptidesIBA
01/2019 - 04/2002
4agomelatine (S20098)IBA
01/2018 - 01/2009
4Neurotransmitter Agents (Neurotransmitter)IBA
09/2013 - 09/2005
4Tryptamines (Triptans)IBA
09/2012 - 12/2002
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2011 - 04/2006
4Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
04/2011 - 03/2004
4AutoreceptorsIBA
12/2008 - 05/2003
4CytokinesIBA
08/2008 - 06/2003
3Mefloquine (Lariam)FDA LinkGeneric
01/2020 - 12/2016
3LigandsIBA
11/2012 - 02/2007
3serotonin 7 receptorIBA
11/2012 - 05/2008
3Peptides (Polypeptides)IBA
04/2012 - 07/2004
3proenkephalinIBA
09/2009 - 03/2004
3Antipsychotic Agents (Antipsychotics)IBA
05/2008 - 03/2005
3cizolirtineIBA
02/2007 - 07/2003
2Donepezil (Aricept)FDA LinkGeneric
01/2020 - 01/2020
2Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2020 - 01/2020
2Morphine (MS Contin)FDA LinkGeneric
01/2019 - 11/2015
2Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
01/2018 - 12/2016
2MelatoninIBA
01/2018 - 05/2013
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2015 - 05/2011
2cyclotraxin-BIBA
10/2014 - 06/2012
2Phosphotransferases (Kinase)IBA
10/2014 - 03/2004
2gamma-Aminobutyric Acid (GABA)IBA
11/2012 - 05/2009
2CitalopramFDA LinkGeneric
09/2012 - 08/2003
23,N- dimethyl- N- (1- methyl- 3- (4- methylpiperidin- 1- yl)propyl)benzenesulfonamideIBA
06/2010 - 02/2009
25-HT1B Serotonin ReceptorIBA
02/2010 - 01/2002
2Tetrodotoxin (Tetradotoxin)IBA
02/2010 - 05/2008
2EndocannabinoidsIBA
05/2009 - 01/2008
2phenyl biguanideIBA
05/2009 - 09/2002
2N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA
02/2009 - 05/2006
2Interleukin-6 (Interleukin 6)IBA
08/2008 - 05/2008
2Calcitonin Gene-Related PeptideIBA
05/2008 - 07/2004
2Transcription Factors (Transcription Factor)IBA
04/2007 - 04/2007
2Streptozocin (Streptozotocin)FDA Link
02/2007 - 07/2004
2CorticosteroneIBA
08/2006 - 01/2006
2MonocrotalineIBA
05/2006 - 05/2005
2Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
05/2004 - 01/2003
2Adrenergic Receptors (Adrenergic Receptor)IBA
02/2004 - 12/2002
2Isoproterenol (Isoprenaline)FDA LinkGeneric
02/2004 - 12/2002
1Drug CombinationsIBA
01/2020
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2020
1PlasticsIBA
12/2019
1Connexin 43 (Connexin43)IBA
12/2019
12- amino- 4- (4- fluoronaphth- 1- yl)- 6- isopropylpyrimidineIBA
01/2018
1Gabapentin (Neurontin)FDA LinkGeneric
01/2018
16- chloro- 5- methyl- 1- ((2- (2- methylpyrid- 3- yloxy)pyrid- 5- yl)carbamoyl)indolineIBA
01/2018
1Serotonin 5-HT2 Receptor AntagonistsIBA
01/2018
1MT2 Melatonin ReceptorIBA
01/2018
1Serotonin AntagonistsIBA
01/2018
1CarrageenanIBA
02/2017
1Formaldehyde (Formol)FDA Link
02/2017
1ConnexinsIBA
12/2016

Therapy/Procedure

8Ligation
01/2018 - 12/2002
5Therapeutics
12/2016 - 04/2005
2Epidural Injections
11/2008 - 07/2008
2Anesthesia
01/2006 - 07/2004
1Aftercare (After-Treatment)
01/2019